Acupuncture Better than Medical Therapy for Migraine Prophylaxis: Study

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-03-25 14:32 GMT   |   Update On 2021-03-26 07:42 GMT

Migraine is a common disabling primary headache disorder, with the prevalence increases at the age of 35-39 years and in the female sex. Despite the great progress in pharmacologic treatment, patients often remain unsatisfied because of low pain control or the associated unacceptable adverse effects. A recent study suggests that acupuncture is safe and effective as a first-line migraine...

Login or Register to read the full article

Migraine is a common disabling primary headache disorder, with the prevalence increases at the age of 35-39 years and in the female sex. Despite the great progress in pharmacologic treatment, patients often remain unsatisfied because of low pain control or the associated unacceptable adverse effects. A recent study suggests that acupuncture is safe and effective as a first-line migraine treatment when compared with a variety of pharmacologic interventions. The study findings were published in the Frontiers in Neurology on January 15, 2021.

A large corpus of evidence has reported encouraging results for acupuncture as a prophylaxis therapy of migraine. However, trials that investigated the efficacy of acupuncture in comparison with pharmacological treatment in episodic migraine showed conflicting results. Therefore, researchers of Italy conducted a study to evaluate if acupuncture is as effective as evidence-based pharmacological drugs in episodic migraine prophylaxis.

It was a randomized, controlled, open-label, multicenter study of 148 patients suffering from migraine without preventive treatment in the past 3months. The researchers randomly assigned the patients into two groups:

♦ The acupuncture group (A) (n=69)who was treated with 12 sessions of acupuncture, and

 The pharmacological group (B) (n=66) who was treated with the most appropriate medication for each patient.

The researchers compared the headache frequency at baseline and at the end of treatment and evaluated both the group at 3 and 6 months after treatment.

Key findings of the study were:

  • The researchers found no significant difference between the groups at baseline.
  • However, After 4 months, they found that the migraine frequency decreased from 8.58 ± 3.21 to 6.43 ± 3.45 in the A group and from 8.29 ± 2.72 to 6.27 ± 4.01 in the B group.
  • They observed that the headache frequency decreased significantly after treatment without differences between the two groups (time-effect: p < 0.001; group effect: p = 0.332; interaction time-group effects: p = 0.556).
  • They noted that patients in both groups responded to treatment, with approximately 34% of patients experiencing a 50% reduction in headaches.
  • They observed a consistent improvement at the end of the treatment in 57.3% (59/103) after 3 months and 38.8% (40/103) after 6 months, especially in patients randomized to the group A.

The authors concluded, "Our trial is the first one comparing acupuncture with the more appropriate pharmacological treatment for migraine prophylaxis. Data suggested that acupuncture could be adopted as migraine prophylaxis and seem to be slightly superior to pharmacological treatment in compliance and rate of adverse events."

For further information:

https://www.frontiersin.org/articles/10.3389/fneur.2020.570335/full


Tags:    
Article Source :  Frontiers in Neurology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News